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Abstract. 
 
Voltage-gated sodium channels (VGSCs) are 
concentrated in the depths of the postsynaptic folds at 
mammalian neuromuscular junctions (NMJs) where 
they facilitate action potential generation during neuro-
muscular transmission. At the nodes of Ranvier and the 
axon hillocks of central neurons, VGSCs are associated 
with the cytoskeletal proteins, 
 
b
 
-spectrin and ankyrin, 
which may help to maintain the high local density of 
VGSCs. Here we show in skeletal muscle, using immu-
nofluorescence, that 
 
b
 
-spectrin is precisely colocalized 
with both VGSCs and ankyrin
 
G
 
, the nodal isoform of 
ankyrin. In en face views of rat NMJs, acetylcholine re-
ceptors (AChRs), and utrophin immunolabeling are or-
ganized in distinctive linear arrays corresponding to the 
crests of the postsynaptic folds. In contrast, 
 
b
 
-spectrin, 
VGSCs, and ankyrin
 
G
 
 have a punctate distribution that 
extends laterally beyond the AChRs, consistent with a 
localization in the depths of the folds. Double antibody 
labeling shows that 
 
b
 
-spectrin is precisely colocalized 
with both VGSCs and ankyrin
 
G
 
 at the NMJ. Further-
more, quantification of immunofluorescence in labeled 
transverse sections reveals that 
 
b
 
-spectrin is also con-
centrated in perijunctional regions, in parallel with an 
increase in labeling of VGSCs and ankyrin
 
G
 
, but not of 
dystrophin. These observations suggest that interac-
tions with 
 
b
 
-spectrin and ankyrin
 
G
 
 help to maintain the 
concentration of VGSCs at the NMJ and that a com-
mon mechanism exists throughout the nervous system 
for clustering VGSCs at a high density.
 
S
 
egregation 
 
of ion channels into distinct domains of
the plasma membrane is important for the function
of many cells. A major issue for neurobiology is
how integral membrane proteins, such as acetylcholine re-
ceptors (AChRs)
 
1
 
 and voltage-gated sodium channels
(VGSCs) become restricted to particular membrane do-
mains rather than remaining freely mobile in the mem-
brane. Association with the spectrin-based cytoskeleton
represents one possible mechanism (for review see Ben-
nett, 1990; Bennett and Gilligan, 1993). Spectrin was first
characterized in red blood cells (RBCs) where anion ex-
changer channels in the membrane are linked through
ankyrin and spectrin to the underlying actin cytoskeleton.
A similar mechanism may contribute to ion channel local-
ization in the nervous system.
One particularly important class of ion channels in excit-
able cells is the VGSCs, which are essential for the initia-
tion of action potentials in most nerve and muscle cells. In
the nervous system, VGSCs have been shown to be clus-
tered at axon hillocks and initial segments (Wollner and
Catterall, 1986; Angelides et al., 1988) where they are re-
sponsible for initiating action potentials, and at nodes of
Ranvier in both peripheral and central neurons (Waxman
and Ritchie, 1985; Kaplan et al., 1997) where they mediate
saltatory conduction in myelinated axons. In skeletal mus-
cle, electrophysiological studies using loose-patch voltage
clamp recording have shown that VGSCs are nonuniformly
distributed with high sodium current densities present at
the neuromuscular junction (NMJ) and in the perijunc-
tional region (Betz et al., 1984; Beam et al., 1985; Caldwell
et al., 1986). These findings were subsequently confirmed
by immunofluorescence studies (Angelides, 1986; Hai-
movich et al., 1987) and EM immunolabeling, which fur-
ther revealed that VGSCs are concentrated in the depths
of the postsynaptic folds and in the perisynaptic mem-
brane, although excluded from the AChR-rich domain at
the tops of the folds (Flucher and Daniels, 1989; Le Treut
et al., 1990; Boudier et al., 1992). The presence of a high
density of VGSCs at the NMJ is believed to lower the
threshold for action potential generation (Wood and
Slater, 1995) and to increase the safety factor for neuro-
muscular transmission (Wood and Slater, 1997).
There is considerable interest in the molecular mecha-
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nisms that account for VGSC clustering at sites of action
potential generation. It has been suggested that interac-
tions with ankyrin and spectrin may play a role in main-
taining a high density of VGSCs (Srinivasan et al., 1988).
Although originally described in RBCs, isoforms of both
spectrin and ankyrin have been identified throughout the
nervous system. Spectrin is a flexible rod-shaped protein
made up of homologous 
 
a
 
 and 
 
b
 
 subunits (Bennett, 1990;
Bennett and Gilligan, 1993). The 
 
b
 
 subunit contains both
the actin-binding site at the NH
 
2
 
 terminus and the ankyrin
binding site in the midregion. An isoform of 
 
b
 
-spectrin has
been shown to be present at the NMJ and in extrajunc-
tional muscle membrane (Bloch and Morrow, 1989; Be-
wick et al., 1992). Bewick et al. (1992) observed that the
distribution of 
 
b
 
-spectrin was quite distinct from that of
AChRs, and suggested that 
 
b
 
-spectrin was in fact localized
to the troughs of the postsynaptic folds. Spectrin is a mem-
ber of a family of structurally related cytoskeleton proteins
including utrophin and the muscle-specific dystrophin.
Whereas the function of these two proteins is as yet un-
clear, their distribution in muscle fibers is well described.
Utrophin is associated with AChRs at the NMJ (Ohlen-
diek et al., 1991; Bewick et al., 1992) and is implicated in
stabilizing AChR clusters at the tops of the postsynaptic
folds (Apel and Merlie, 1995). On the other hand, dystro-
phin, like 
 
b
 
-spectrin, is found throughout the muscle fiber
membrane and is concentrated at the NMJ where it is
thought to be localized in the depths of the folds (Sealock
et al., 1991; Yeadon et al., 1991; Bewick et al., 1992). This
localization raises the possibility that both 
 
b
 
-spectrin and
dystrophin may have a role in localizing VGSCs to the
depths of the postsynaptic folds.
Ankyrins are a family of peripheral membrane proteins
that have been shown to interact with both ion channels
and 
 
b
 
-spectrin. It is now clear that there are at least three
separate genes encoding the ankyrin family of proteins (for
review see Lambert and Bennett, 1993). The first mem-
bers of the ankyrin family described were ankyrin
 
B
 
, which
is the major ankyrin in the nervous system, and ankyrin
 
R
 
,
which is present in RBCs and has a restricted distribution
in the nervous system. More recently, a third ankyrin,
ankyrin
 
G
 
, has been described; it is the largest ankyrin
found to date (Kordeli et al., 1995). An isoform of anky-
rin
 
G
 
 is present at the nodes of Ranvier and at the initial
segment of axons in central neurons (Kordeli et al., 1990;
Kordeli and Bennett, 1991; Kordeli et al., 1995; Kaplan et al.,
1997), suggesting that ankyrin
 
G
 
 mediates the interaction
between VGSCs and spectrin in these regions. Using an anti-
body raised against RBCs, ankyrin immunoreactivity has
been shown to be localized at the NMJ in the depths of the
postsynaptic folds (Flucher and Daniels, 1989) suggesting
that a similar interaction may account for the high density
of VGSCs at the NMJ.
If ankyrin
 
G
 
 and 
 
b
 
-spectrin mediate VGSC clustering,
then it would be expected that these three proteins would
be codistributed. Whereas there is much evidence suggest-
ing that the 
 
b
 
-spectrin–ankyrin interaction is important for
aggregating VGSCs in neurons, the in situ colocalization
of these three proteins has not been explicitly demon-
strated. Here we have used immunofluorescence labeling
to ask whether, in skeletal muscle, 
 
b
 
-spectrin is colocalized
with both VGSCs and the isoform of ankyrin found at the
nodes of Ranvier, ankyrin
 
G
 
. For comparison with 
 
b
 
-spec-
trin, we have also examined the distribution of the related
cytoskeletal proteins utrophin and dystrophin to identify
whether they are colocalized with VGSCs and ankyrin
 
G
 
.
This study is a prerequisite to developmental studies that
may give insight into how distinct VGSC–cytoskeleton do-
mains are assembled and maintained.
 
Materials and Methods
 
Tissues
 
Soleus muscles isolated from adult female rats (
 
z
 
200 g) were used
throughout the experiments. For immunolabeling, the muscles were pre-
pared in one of two ways. Whole muscles were lightly fixed in paraformal-
dehyde (0.5% wt/vol) for 30 min, and then washed in PBS. The muscles
were then teased into small bundles of 5–15 fibers and permeabilized with
Triton X-100 (1% vol/vol) in PBS for 30 min. These teased fibers, which
allow NMJs to be viewed en face, were then immunolabeled as outlined
below. Alternatively, muscles were prepared for cryosectioning by freez-
ing blocks of muscle in isopentane cooled in liquid nitrogen. Transverse
cryostat sections (6 
 
m
 
m) of the soleus muscles were cut and thaw mounted
onto gelatine-coated slides. After air drying for 60 min, these slides were
wrapped and stored at 
 
2
 
40
 
8
 
C until required. Transverse cryosections of
control and 
 
mdx
 
 mouse epitrochleoanconeous (ETA) muscles were simi-
larly prepared.
 
Antibodies
 
The following primary antibodies were diluted in PBS containing 3%
BSA and 0.1 M lysine as indicated. Two previously described monoclonal
antibodies that recognize 
 
b
 
-spectrin, raised against human RBC ghosts,
were used. NCLSPEC2 was used in sections (1:30; Novacastra, Burlin-
game, CA) and RBC2/5C4 (Bewick et al., 1992) was used in teased fibers
(1:2; a gift from Dr. L. Anderson, University of Newcastle upon Tyne). An
affinity-purified rabbit polyclonal raised against peptides unique to the rat
ankyrin
 
G
 
 spectrin-binding domain Ank
 
G
 
@SpBd was used in sections at
0.01 
 
m
 
g/
 
m
 
l and in teased fibers at 0.02 
 
m
 
g/
 
m
 
l (a gift from Dr. S. Lambert,
Worcester Foundation for Biomedical Research, Shrewsbury, MA) (Ko-
rdeli et al., 1995). For VGSC labeling, a rabbit polyclonal antibody
AP1380 raised against a synthetic peptide EOIII, which recognizes the
highly conserved segment in the intracellular III–IV loop that is present in
all known vertebrate sodium channels (a gift from Dr. R. Levinson, Uni-
versity of Colorado School of Medicine, Denver, CO) (Dugandzija-Nova-
kovic et al., 1995) was used at a dilution of 1:30 in sections and 1:10 for
teased fibers. Control experiments where the VGSC antibody (2 
 
m
 
l) was
preabsorbed with the peptide antigen EOIII (1 
 
m
 
g in 1 
 
m
 
l) overnight at
4
 
8
 
C and then applied to the tissues revealed no significant labeling above
the no primary control (Fig. 1). A monoclonal antibody DY8/6C5 to a
COOH-terminal epitope of dystrophin was used at 1:50 in sections and at
1:10 in teased fibers (a gift from Dr. L. Anderson) (Bewick et al., 1992). A
monoclonal antibody DRP3/20C5, raised against a fusion protein contain-
ing the first 261 NH
 
2
 
-terminal amino acids of the utrophin sequence, was
used at 1:10 in both sections and in teased fibers (a gift from Dr. L. Ander-
son) (also available as antibody NCLDRP2; Novacastra).
TRITC-conjugated swine anti–rabbit or rabbit anti–mouse IGs (Dako
Ltd., High Wycombe, UK) were used as secondary antibodies in most ex-
periments to recognize polyclonal and monoclonal primary antibodies, re-
spectively. For double antibody–labeling experiments monoclonal pri-
mary antibodies were detected using a FITC-conjugated goat anti–mouse
secondary (Dako Ltd.). All secondary antibodies were diluted at 1:100.
 
Immunolabeling
 
All incubations and washings were performed at room temperature ex-
cept where stated and PBS was used for all washes.
Permeabilized, teased muscle fibers were incubated in primary anti-
bodies overnight (at least 15 h) at 4
 
8
 
C. After allowing the fibers to warm
to room temperature for 45 min, the bundles were washed for 45 min, and
then incubated for 2 h in secondary antibodies. The secondary antibodies
were preincubated with normal rat serum at a ratio of 2:1 for 1 h at room
temperature before dilution. To enable NMJs to be identified, FITC
 
a
 
-bungarotoxin (BgTx) (6 
 
3
 
 10
 
2
 
7
 
 M; Molecular Probes, Inc., Eugene, OR), 
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which labels AChRs, was added with the secondary antibody solution.
Subsequently, the fibers were washed (30 min), fixed in paraformaldehyde
(1% wt/vol for 15 min), and then mounted on microscope slides in antifad-
ing fluorescence mounting medium (Vectashield; Vector Laboratories,
Inc., Burlingame, CA). As a control, an identical labeling procedure was
carried out with the omission of the primary antibody where diluent was
applied instead.
Slide-mounted transverse sections were removed from the freezer and
warmed to room temperature. Before labeling with primary antibodies,
the unfixed sections were washed first with 0.1% Triton X-100 (vol/vol)
for 5 min, and then washed for 15 min. The labeling procedure for sections
and teased fibers was then essentially the same.
To examine the colocalization of proteins, double antibody labeling
was performed with a monoclonal antibody to 
 
b
 
-spectrin, dystrophin, or
utrophin and a polyclonal antibody to either VGSCs or ankyrin
 
G
 
 in both
serial sections and in teased fiber preparations. Tissues were incubated in
primary monoclonal antibodies for 6 h at 4
 
8
 
C, allowed to warm to room
temperature, and washed as above. This was followed by incubation with
FITC-conjugated goat anti–mouse for 2 h, a wash for 1 h, and then the pri-
mary polyclonal antibody was applied for 10 h at 4
 
8
 
C. Again the tissues
were allowed to warm to room temperature, and were then washed before
incubation with TRITC-conjugated swine anti–rabbit for 2 h. Finally the
tissues were washed, fixed, and mounted as described above.
 
Microscopy
 
Double antibody–labeled transverse sections were photographed on an
Optiphot-2 microscope using a 
 
3
 
40 oil Plan apo objective (Nikon UK
Ltd., Kingston, UK). The rhodamine and fluorescein fluorescence were
viewed with Nikon G-2A and B-2A filter sets, respectively. A525/20 nm
bandpass emission filter (Leica UK Plc., Milkon Keynes, UK) was used to
enhance the selectivity of the fluorescein images by preventing rhodamine
“bleed through.”
In addition, digitized images of labeled specimens were recorded using
a cooled CCD camera imaging system (Astrocam, Cambridge, UK) and
either a 
 
3
 
50 (Leitz) or a 
 
3
 
100 (Nikon) plan fluor oil immersion objectives
on a M2B microscope (Micro Instruments Ltd., Oxford, UK) using Nikon
filter blocks, G-1B (TRITC) and B-2H (FITC), with the additional narrow
bandpass filter to improve fluorescein selectivity. All the digitized images
were stored on optical disks for subsequent analysis using Imager 2
 
1
 
 soft-
ware (Astrocam, Cambridge, UK) as outlined below.
To determine the localization of immunolabeling within the postsynap-
tic folds, double-labeled en face NMJs were also viewed with a confocal
laser microscope (laser 
 
l
 
 488 nm for FITC; laser 
 
l
 
 568 nm for rhodamine)
(MRC600; Bio-Rad Laboratories, Hercules, CA) using a 
 
3
 
60 objective
(NA 1.4). NMJs were initially viewed en face. A line of interest was se-
lected, through which a series of scans at different focal depths (0.3-
 
m
 
m
steps) was made. From such series reconstructed transverse sections were
produced. Subsequently, the entire NMJ was scanned in 10–15 steps of
0.5 
 
m
 
m to construct a complete en face view. The position of the trans-
verse section was clearly identified in en face views where the fluores-
cence had been bleached.
 
Quantification
 
Images of both fluorescein and rhodamine labeling were recorded from
transverse sections of muscle fibers that were dual labeled with a primary
antibody to the protein of interest and with BgTx. The presence of FITC-
 
a
 
-BgTx binding to AChRs was used to identify the position of the NMJ
(Fig. 2), and the corresponding rhodamine image demonstrates the pres-
ence of VGSC immunolabeling around the entire muscle fiber membrane.
The intensity of fluorescence was measured in each of three regions of the
muscle fiber surface (Fig. 2): the NMJ (
 
J
 
); the perijunctional region (
 
PJ
 
)
immediately adjacent (0–5 
 
m
 
m) to the NMJ; and an extrajunctional region
(
 
XJ
 
) diametrically opposed to the NMJ. For all the images obtained the
camera was operating within a range where pixel intensity and exposure
time were linearly related. All intensity values were expressed as gray lev-
els per second of exposure time. The total fluorescence intensity within
each region was calculated and the value obtained was divided by the area
of the region to give the mean intensity of labeling per unit area. A back-
ground value determined by applying the same procedure to sections in
which the primary antibody had been omitted was subtracted to give the
Figure 1. Specificity of immunolabeling of VGSCs. Digitized im-
ages of transverse sections of rat soleus muscle were dual labeled
with FITC a-BgTx to identify AChRs at the NMJ and antibody
to VGSCs (AP1380); antibody to VGSCs preincubated with the
immunogenic peptide against which it was raised (AP1380/EOIII)
or no primary antibody (diluent). All were visualized with TRITC
secondary antibody. The images are printed so that the intensity
levels in each column are comparable. Bar, 20 mm.
Figure 2. Identification of
junctional (J), perijunctional
(PJ), and extrajunctional
(XJ) regions in immunola-
beled transverse sections of
rat soleus muscles. For analy-
sis of immunofluorescence
labeling intensity, sections
were dual labeled with FITC
a-BgTx to identify the
AChRs at the NMJ and an
antibody to the protein of in-
terest, in this example poly-
clonal antibody to VGSCs
(AP1380). Once J, PJ, and
XJ regions were defined as
described in the Materials
and Methods, the mean fluo-
rescence labeling intensity
within each of them was de-
termined. Bar, 20 mm. 
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net labeling intensity. For each muscle fiber, the mean fluorescence inten-
sity in J and PJ regions was normalized to that in the XJ region (assigned a
value of 1). For each antibody, 10 muscle fibers in each of two soleus mus-
cles were analyzed, and the results expressed as mean normalized fluores-
cence intensity 
 
6
 
 SEM.
An important preliminary step in this quantification procedure was to
establish an appropriate primary antibody dilution. If the fluorescence in-
tensity is to be proportional to the number of protein molecules, then the
primary antibodies should be used at or near saturating concentration.
Using serial dilution experiments, an approximately saturating antibody
concentration was determined for the primary antibodies to VGSC, anky-
rin
 
G
 
, 
 
b
 
-spectrin, and dystrophin. Fig. 3 shows an example of a dilution se-
ries for the NCLSPEC2 antibody to 
 
b
 
-spectrin. Muscle sections were ex-
posed to serial dilutions of antibody and images containing NMJs were
analyzed for J and XJ labeling as outlined above (without normalizing the
labeling intensity to extrajunctional levels). The mean fluorescence label-
ing intensity per 
 
m
 
m
 
2
 
 in both J and XJ regions was plotted against anti-
body concentration (Fig. 3). Each point is the mean 
 
6
 
 SEM of observa-
tions from six muscle fibers. The concentration at which the binding sites
appeared saturated was used to label sections throughout the experi-
ments. At this dilution, the greatest difference between labeling intensity
in J and XJ regions of the muscle fiber can be seen.
 
Results
 
Distribution of VGSCs and Cytoskeletal Proteins at
the NMJ
 
b
 
-Spectrin, a cytoskeletal protein implicated in the main-
tenance of VGSC clusters throughout the nervous system,
is concentrated at the NMJ (Bloch and Morrow, 1989; Be-
wick et al., 1992). To see whether it is well placed within the
NMJ to interact with VGSCs, the distribution of both VGSCs
and 
 
b
 
-spectrin was examined using confocal microscopy
(Fig. 4). Dual-labeled teased muscle fibers viewed en face
show that both VGSCs and 
 
b
 
-spectrin are approximately
codistributed with AChRs at the NMJ (Fig. 4). The super-
imposed images show clearly that labeling for both VGSCs
and 
 
b
 
-spectrin extends laterally 
 
z
 
0.5 
 
m
 
m beyond that for
AChRs. Bewick et al. (1993) reported that in en face views
of NMJs a fringe of dystrophin or 
 
b
 
-dystroglycan labeling
could be seen to extend beyond AChR labeling. These au-
thors interpreted this observed fringe of labeling as repre-
senting immunolabeling in the bottom of the postsynaptic
folds.
To determine the localization of 
 
b
 
-spectrin and VGSC
immunolabeling within the postsynaptic folds, reconstructed
transverse sections through the NMJ were produced.
These images (Fig. 4) show that there are two discrete ion
channel domains at the NMJ with AChR labeling and
Figure 3. Example of the
effect of antibody dilution
on immunolabeling fluores-
cence intensity. Transverse
cryostat sections of rat soleus
muscle were dual labeled
with an antibody against
b-spectrin (NCLSPEC2), vi-
sualized with a TRITC sec-
ondary antibody, and with
FITC  a-BgTx to identify the
NMJ. Each point is the mean
(6 SEM) fluorescence inten-
sity in junctional (s) and ex-
trajunctional (d) regions of
six muscle fibers. For the
b-spectrin antibody, the dilution at which most of the antigen
binding sites are saturated is 1:30.
Figure 4. Pseudo-colored
confocal micrographs of rat
soleus NMJs. Teased fiber
preparations were dual labeled
with FITC a-BgTx (green)
to identify AChRs and anti-
bodies to VGSCs (AP 1380)
or b-spectrin (RBC2/5C4) vi-
sualized with TRITC second-
ary antibodies (red). Both en
face and reconstructed trans-
verse views are shown. The
superimposed en face images
reveal a fringe of VGSC or
b-spectrin labeling that ex-
tends laterally beyond the
AChR labeling (Superim-
posed and Detail). Trans-
verse views (at the position
of the white lines) show that
this fringe is also present on
the cytoplasmic surface of the
AChR domain. This pattern
of labeling is consistent with
the localization of AChRs at
the tops of the postsynaptic
folds and of VGSC and
b-spectrin in the depths of
the folds. Bar, 10 mm.Wood and Slater b-Spectrin at Rat Neuromuscular Junctions 679
VGSC immunolabeling having distinctly different spatial
distributions. These observations are consistent with a pre-
vious study (Flucher and Daniels, 1989) that showed, using
EM immunogold labeling, that VGSCs are concentrated
in the depths of the postsynaptic folds and largely ex-
cluded from the AChR-rich domain at the tops of the folds.
Moreover, the pattern of b-spectrin immunolabeling is
similar to that of VGSC labeling in both en face views and
in reconstructed transverse sections (Fig. 4). This indicates
that b-spectrin, like VGSCs, is present in the depths of the
postsynaptic folds. An isoform of b-spectrin has previously
been reported to be associated with AChRs in myotube
cultures and at adult rat NMJs (Bloch and Morrow, 1989).
Our results show that an isoform of b-spectrin is present at
NMJs, which is clearly associated with VGSC-rich do-
mains and not with AChRs, indicating that there may be
multiple b-spectrin isoforms in skeletal muscle.
If ankyrinG is an intermediary in the binding of VGSCs
and b-spectrin at the NMJ then its distribution would be
expected to be similar to that of VGSCs. In low magnifica-
tion en face views of NMJs, immunolabeling for both VGSCs
and ankyrinG is concentrated at the adult NMJ and is ap-
proximately codistributed with the AChRs (Fig. 5). On
closer examination however, it can be seen that labeling
for ankyrinG extends laterally beyond that for AChRs, as
does immunolabeling for VGSCs and b-spectrin (Fig. 4).
At higher magnification, differences in the detail of the la-
beling patterns can be seen (Fig. 5, arrows). Whereas
AChRs seem to be organized in a characteristic linear pat-
tern corresponding to the crests of the postsynaptic folds,
VGSCs and ankyrinG have a more punctate distribution
with some features of the labeling pattern being quite dif-
ferent from that of the AChR labeling. Fig. 5 thus con-
firms and extends the observations of Flucher and Daniels
(1989), which found that VGSCs and ankyrin are localized
in the depths of the postsynaptic folds. However, we have
used different antibodies, in particular the antibody used
here to demonstrate ankyrin labeling is specific for the iso-
form of ankyrin found at the nodes of Ranvier—ankyrinG
(Kordeli et al., 1995).
To test directly the hypothesis that b-spectrin is colocal-
ized with VGSCs, teased fibers were double labeled with
antibodies to VGSCs and with antibodies to the structur-
ally related cytoskeletal proteins b-spectrin, dystrophin,
and utrophin (Fig. 6). The distribution of immunolabeling
of both b-spectrin and dystrophin was found to be strik-
ingly similar to that of VGSCs (Fig 6, arrows). However,
occasionally, very slight differences in the fine pattern of
dystrophin and VGSC labeling could be detected. In con-
trast, utrophin immunolabeling was quite different to that
of VGSCs, often resembling a more linear pattern similar
to that associated with AChR labeling (Fig. 5). These ob-
servations suggest that the two distinct ion channel domains
occupied by VGSCs and AChRs at the NMJ are matched
by distinct cytoskeletal protein domains, with b-spectrin
and dystrophin (but not utrophin) being colocalized with
VGSCs.
Distribution of VGSCs and Cytoskeletal Proteins in the 
PJ Region
Electrophysiological and EM labeling studies have sug-
gested that the local high density of VGSCs is not confined
to the NMJ but extends into the perijunctional region
(Caldwell et al., 1986; Flucher and Daniels, 1989; Le Treut
et al., 1990). Therefore, the distribution of VGSCs and cy-
toskeletal proteins was examined in transverse sections of
muscle that allow the entire circumference of the muscle
fiber membrane to be examined. Dual labeling confirms
that VGSC immunolabeling is concentrated at the NMJ
Figure 5. Comparison of the distribution of VGSCs and ankyrinG with that of AChRs in en face views of the NMJ. Digitized images are
shown of teased fiber preparations from rat soleus muscles dual labeled with an antibody to either VGSCs (AP1380) or ankyrinG
(AnkG@SpBd) and FITC a-BgTx to identify AChRs. Low magnification images (350 objective; Bar, 20 mm) show the overall distribu-
tion of immunolabeling at the NMJ. At higher magnification (3100 objective; Bar, 10 mm), arrows highlight areas where AChRs are or-
ganized in a linear fashion, whereas VGSCs and ankyrinG have a more spotty distribution that clearly extends beyond the AChR region.The Journal of Cell Biology, Volume 140, 1998 680
(Fig. 7). As expected, VGSC immunolabeling was not uni-
formly distributed in the rest of the muscle fiber but ap-
peared to be concentrated in regions close to the NMJ. In-
terestingly, subsequent serial sections through the same
NMJ shows that this perijunctional increase in VGSC
labeling is matched by increased immunolabeling for
b-spectrin but not for dystrophin (Fig. 7, arrows). Utrophin
immunolabeling acts as a control for the double antibody–
labeling technique. Since immunolabeling for utrophin is
restricted to the NMJ and to intramuscular blood vessels it
can clearly be seen that there is no inappropriate cross-
reaction between the antibodies used in this procedure
(Fig. 7). These observations suggest that in the perijunc-
tional region, as at the NMJ, the concentration of b-spectrin
closely parallels that of VGSCs but the concentration of
dystrophin does not.
If VGSC clustering is mediated via an interaction be-
tween ankyrinG and b-spectrin, then ankyrinG would also
be expected to be concentrated at the NMJ and in the peri-
junctional region. The distribution of ankyrinG immunola-
beling in the muscle fiber membrane was therefore exam-
ined and compared with that of the cytoskeletal proteins
b-spectrin, utrophin, and dystrophin. Transverse sections
were dual labeled with ankyrinG antibody and BgTx to al-
low the NMJ to be identified (Fig. 8). AnkyrinG appeared
concentrated at the NMJ and in adjacent regions, com-
pared with extrajunctional regions. Subsequent serial sec-
tions were double antibody labeled and revealed that like
VGSCs, the perijunctional concentration of ankyrinG im-
munolabeling is mirrored by b-spectrin (Fig. 8), but not by
dystrophin or utrophin (data not shown). Thus ankyrinG
and b-spectrin are colocalized at the NMJ and in the peri-
junctional region where the concentration of ankyrinG ap-
pears to parallel that of b-spectrin.
In addition to sarcolemmal immunolabeling, Fig. 8 also
reveals the presence of myoplasmic labeling by the anky-
rinG antibody. The specificity of this myoplasmic labeling
is confirmed by comparing Figs. 7 and 8, in which double
primary antibody labeling is illustrated. In both figures the
secondary antibodies used are the same. However, addi-
tional labeling of blood vessels is specific to the utrophin
antibody (Fig. 7), and myoplasmic labeling is specific to
the ankyrinG antibody (Fig. 8). Devarajan et al. (1996) iden-
tified a truncated isoform of ankyrinG, ankG119, in kidney
Figure 6. The distribution of VGSCs and the cytoskeletal proteins b-spectrin, dystrophin, and utrophin in en face views of the NMJ.
Teased fiber preparations of rat soleus muscles were double labeled with a polyclonal antibody to VGSCs (AP1380; visualized with
TRITC secondary antibody), and monoclonal antibodies for b-spectrin (RBC2/5C4), dystrophin (DY8/6C5), and utrophin (DRP3/
20C5) all visualized with FITC secondary antibody. Low magnification images (350 objective; Bar, 20 mm) show the overall distribution
of immunolabeling at the NMJ. At higher magnification (3100 objective; Bar, 10 mm), arrows highlight distinctive features of the immu-
nolabeling patterns. Labeling of both b-spectrin and dystrophin resembles the punctate distribution of VGSC immunolabeling at the
NMJ. b-Spectrin appears to be precisely colocalized with VGSCs, there are subtle differences in the VGSC and dystrophin distributions
whereas VGSCs and utrophin have distinctly different labeling patterns.Wood and Slater b-Spectrin at Rat Neuromuscular Junctions 681
cells that binds spectrin but does not associate with the
plasma membrane. Northern blot analysis of the mRNA
for this truncated ankyrinG isoform indicated that this iso-
form was also present in skeletal muscle (Devarajan et al.,
1996). The immunolabeling seen in this study could corre-
spond to this truncated ankyrinG isoform.
Quantification
To assess the intensity of immunolabeling for VGSCs,
ankyrinG,  b-spectrin, and dystrophin regions of J, PJ, and
XJ labeling were identified in transverse muscle sections (as
in Fig. 2). The mean fluorescence labeling intensity per
mm2 in each region was measured and normalized to that
in the XJ region (Fig. 9). All the proteins studied are
clearly concentrated at the NMJ. The cytoskeletal proteins
ankyrinG,  b-spectrin, and dystrophin are all increased
three- to fourfold, whereas VGSCs are increased sixfold
(Fig. 9). The increase in the cytoskeletal proteins is ap-
proximately in line with the increase in membrane at the
NMJ as a result of postsynaptic folding (Wood and Slater,
1997). The greater increase in VGSCs suggests that there
may actually be a higher density of channels per unit area of
membrane within the folds at the NMJ than in XJ regions,
as suggested previously (Caldwell et al., 1986; Flucher and
Daniels, 1989). A highly significant (P , 0.001; t test) peri-
junctional increase of 1.5–2-fold was seen for VGSCs,
ankyrinG, and b-spectrin, but not for dystrophin (Fig. 9).
This analysis indicates that the concentration of b-spectrin
closely parallels that of VGSCs and ankyrinG in the PJ re-
gion, but that the concentration of dystrophin does not.
Distribution of VGSC in the Absence of Dystrophin
Dystrophin and VGSCs are colocalized at the NMJ and
throughout the muscle fiber membrane. Although there is
no increase in dystrophin immunolabeling in the PJ re-
gion, it is still present there. To test for a possible influence
of dystrophin in maintaining the high concentration of
VGSCs at the NMJ, the distribution of VGSCs was exam-
ined in muscles from the mdx mouse, in which a point mu-
tation on the X chromosome results in a profound defi-
ciency of dystrophin (Sicinski et al., 1989). Transverse
sections of ETA muscles from control and mdx mice were
Figure 7. The distribution of VGSCs and the cytoskeletal pro-
teins b-spectrin, dystrophin, and utrophin in rat soleus muscle fi-
bers. Transverse serial sections through the same NMJs were
double labeled with a polyclonal antibody to VGSCs (AP1380; vis-
ualized with TRITC secondary antibody) and FITC a-BgTx to
identify the NMJ, and monoclonal antibodies to b-spectrin (NCL-
SPEC2), dystrophin (DY8/6C5), and utrophin (DRP3/20C5) vi-
sualized with FITC secondary antibody. Immunolabeling for both
b-spectrin and dystrophin is codistributed with that for VGSCs in
the muscle fiber. In the perijunctional region the concentration of
VGSCs parallels that of b-spectrin but not of dystrophin (ar-
rows). Utrophin immunolabeling is intense at NMJs (fainter in
blood vessels) and serves as a control for the specificity of the
secondary antibodies in this double antibody labeling procedure.
Bar, 50 mm.
Figure 8. The distribution of ankyrinG and b-spectrin in rat so-
leus muscle fibers. Transverse serial sections through the same
NMJ were double labeled with a polyclonal antibody to ankyrinG
(AnkG@SpBd; visualized with TRITC-secondary antibody), and
FITC a-BgTx to identify the NMJ, and monoclonal antibody for
b-spectrin (NCLSPEC2) visualized with FITC secondary anti-
body. b-Spectrin and ankyrinG are concentrated at the NMJ and
in perijunctional regions (arrows). Immunolabeling for ankyrinG
is also seen in the myoplasm. Bar, 50 mm.The Journal of Cell Biology, Volume 140, 1998 682
dual labeled with BgTx, to identify the NMJs and the
VGSC antibody. Both in the presence and absence of dys-
trophin, VGSC immunolabeling was clearly concentrated
at the NMJ and in PJ regions of mouse muscle (Fig. 10).
This observation indicates that dystrophin does not play
an essential role in clustering VGSCs at the NMJ in adult
muscle.
Discussion
The main finding of this study is that at adult rat NMJs,
b-spectrin is colocalized with both VGSCs and ankyrinG.
Flucher and Daniels (1989) used EM immunogold labeling
to show that VGSCs are concentrated in the depths of the
postsynaptic folds, whereas AChRs are restricted to the
tops of the folds. We have demonstrated that these two ion
channel domains can be distinguished in en face views of
labeled NMJs. Confocal microscopy of immunolabeled
teased fibers has shown that b-spectrin is clearly associ-
ated with VGSC-rich domains in the depths of the post-
synaptic folds and not colocalized with AChRs. Further-
more, within the NMJ, the punctate pattern of labeling for
VGSCs is mirrored by b-spectrin and by ankyrinG. This
contrasts to the linear arrays of labeling for AChRs and
utrophin, which are thought to correspond to the tops of
the postsynaptic folds. The punctate labeling pattern may
arise from the branching of the folds and their poor align-
ment with the fold openings or from the presence of
VGSC microclusters within the fold membrane. In addition,
we have shown that the concentration of VGSCs in peri-
junctional regions is paralleled by increases in the concen-
tration of both b-spectrin and ankyrinG. The precise colo-
calization of b-spectrin and ankyrinG with VGSCs at the
NMJ and in perijunctional regions suggests that these three
proteins may interact with one another to provide a means
of maintaining a high density of VGSCs at the NMJ.
The muscle cytoskeletal protein dystrophin, a member
of the spectrin family, has previously been shown to have a
similar distribution to that of b-spectrin at the NMJ (Be-
wick et al., 1992). Likewise, in this study dystrophin has a
somewhat punctate distribution at the NMJ that extends
beyond the AChR-labeled regions, suggestive of a local-
ization in the depths of the postsynaptic folds. However,
examination of the labeling pattern of VGSCs and dystro-
phin in greater detail revealed subtle differences. Further-
more, although dystrophin is concentrated at the NMJ, it
is not increased in the perijunctional region. Finally, in
muscles of the mdx mouse (which lacks dystrophin), VGSCs
are normally distributed and concentrated at the NMJ. To-
gether, these observations suggest that dystrophin does
not play a significant role in clustering VGSCs at the NMJ.
Syntrophin, a protein closely associated with dystrophin
and utrophin, contains PSD-95, DIgA, ZO-1–like (PDZ)
domains that in other situations have been implicated in
Figure 9. Comparison of intensity of immunofluorescent labeling
for VGSCs, ankyrinG, b-spectrin, and dystrophin in junctional (J),
perijunctional (PJ), and extrajunctional (XJ) regions of rat soleus
muscle fiber membrane. The mean fluorescence intensity of im-
munolabeling, normalized to XJ, is shown for each protein/anti-
body. J labeling for VGSCs (AP1380) is increased sixfold whereas
labeling for ankyrinG (AnkG@SpBd), b-spectrin (NCLSPEC2),
and dystrophin (DY8/6C5) is increased two- to threefold. PJ la-
beling is increased 1.5–2-fold for all proteins except dystrophin.
Each point is the mean 6 SEM of observations in 20 muscle fi-
bers from two soleus muscles.
Figure 10. Clustering of VGSCs at the NMJ of dystrophin defi-
cient mdx mouse ETA muscle. Transverse sections of control and
mdx ETA muscle were dual labeled with VGSC antibody (AP-
1380) visualized with TRITC secondary antibody and FITC
a-BgTx, which allows NMJs to be identified. VGSCs are obvi-
ously clustered at the NMJ and in perijunctional regions in the
absence of dystrophin. Bar, 20 mm.Wood and Slater b-Spectrin at Rat Neuromuscular Junctions 683
clustering of ion channels (Kim et al., 1995). Recently it
has been reported that VGSCs copurify with syntrophin
and dystrophin in skeletal and cardiac muscle (Gee et al.,
1998). In the mdx mouse, which lacks dystrophin, syntro-
phin and other dystrophin-associated proteins are greatly
reduced in abundance in the XJ region of the muscle fiber
but they persist at the NMJ, presumably in association with
utrophin (Matsumura et al., 1992). Although we have
shown that the distribution of VGSCs in mdx mouse mus-
cle is essentially normal, it remains possible that interac-
tions with syntrophin represent an additional means of lo-
calizing VGSCs at the NMJ.
VGSC Concentration at the NMJ
The concentration of VGSCs in J and PJ regions is likely
to be functionally important. The action potential thresh-
old at the NMJ is lower than in extrajunctional regions
(Wood and Slater, 1995) and the high safety factor for neu-
romuscular transmission may be attributed in part to the
postsynaptic folds and the VGSCs concentrated within them
(Wood and Slater, 1997). Various approaches have been
used to estimate the number of VGSCs at the NMJ. Elec-
trophysiological analyses using loose-patch voltage-clamp
recording to measure sodium current density have sug-
gested that the density of VGSCs at the NMJ was 8,000/mm2
in rat muscle (Caldwell et al., 1986), representing a 20-fold
increase over XJ sodium current densities. This estimate
of channel number was based on values of sodium current
density and related to VGSC-specific toxin binding studies
of the nodes of Ranvier. It was complicated by huge varia-
tions in sodium current density within the NMJ and by un-
certainties concerning the amount of folded membrane in
the patch examined. An alternative approach of EM auto-
radiography, using radiolabeled scorpion toxins, has sub-
sequently suggested that there is a sevenfold increase in
VGSC concentration at the NMJ compared with XJ re-
gions (Le Treut et al., 1990), and that this may correspond
to as many as 5,000 channels per mm2 in the fold mem-
brane (Boudier et al., 1992).
In this study, we have used the intensity of fluorescent
labeling as a measure of VGSC density. Whereas this ap-
proach does not lead to a measure of the absolute number
of VGSCs per unit area, it is useful in providing an indica-
tion of the density of VGSC labeling within the NMJ rela-
tive to that in other parts of the same muscle fiber. Using
this approach, we have found that the intensity of VGSC
labeling is sixfold greater at the NMJ than in XJ regions.
Since VGSCs are localized in the postsynaptic folds, the
folding itself is likely to account for much of this increase.
Folding results in a fivefold increase in the postsynaptic
membrane area at the rat soleus NMJ (Wood and Slater,
1997). However, not all of that folded membrane is occu-
pied by VGSCs. The boundary between the regions of high
AChR and VGSC density occurs about one-third of the
way into the folds (Flucher and Daniels, 1989). This sug-
gests that the actual increase in the amount of membrane
that accommodates VGSCs is about threefold, consistent
with the degree of increased labeling of b-spectrin, anky-
rinG, and dystrophin, which all appear to occupy the same
region of the folds as VGSCs. Thus the sixfold junctional
increase in VGSC labeling indicates that the junctional
VGSC density per unit area is at least twice that in extra-
junctional membrane and that the increase in VGSCs is
clearly more than that for cytoskeletal proteins. Whereas
our value for the increase in local VGSC density is lower
than previous estimates, there are substantial uncertainties
associated with all the methods used.
In the perijunctional region there are no folds, yet sev-
eral studies have suggested that VGSCs are also concen-
trated in the perisynaptic region. Electrophysiological
studies suggest that the perijunctional density is 5–10-fold
greater than that in the extrajunctional region (Beam et al.,
1985; Caldwell et al., 1986), whereas EM studies suggest
that the junctional increase in VGSCs extends into the peri-
junctional region (Le Treut et al., 1990; Boudier et al., 1992).
The observations reported here suggest that the density of
VGSCs in the perijunctional region is 2.5-fold greater than
in the extrajunctional region, and is thus similar to that
within the postsynaptic folds at the NMJ. This increased
VGSC density in the perisynaptic region may function to
ensure the initial spread of depolarization away from the
endplate.
VGSC Clustering and Cytoskeletal Proteins
The factors leading to the increased density of VGSCs at
the NMJ are poorly understood. One possibility is that
VGSCs are preferentially synthesized and inserted into
the membrane in the junctional region. It is well known
that the genes for AChRs and AChE are preferentially
synthesized by postsynaptic myonuclei (Brenner et al., 1990;
Jasmin et al., 1993; Duclert and Changeux, 1995), and re-
cent reports indicate that this is also true for a number of
other postsynaptic molecules including neural cell adhe-
sion molecule, rapsyn, s-laminin (Moscoso et al., 1995),
and utrophin (Gramolini et al., 1997; Vater et al., 1988). If
there is preferential expression of VGSC genes at the
NMJ, then the high concentration of VGSCs at the NMJ
and in perijunctional regions might well result from a gra-
dient of mRNA concentration with its peak at the NMJ.
However, NMJ-specific gene expression is unlikely to be
the entire explanation for the observations reported. It
seems probable that local mechanisms must also exist to
regulate the placement of ion channels at the NMJ since
AChRs, which exhibit synapse-specific gene expression,
are not found in perijunctional regions.
One influence on VGSC distribution and concentration
at the NMJ is likely to be interaction with the underlying
cytoskeleton. Here we have shown very close spatial asso-
ciations between VGSCs and both b-spectrin and ankyrinG.
Studies in nerve cells (Srinivasan et al., 1988; Kordeli et al.,
1990; Joe and Angelides, 1992; Kaplan et al., 1997) have
led to the idea that ankyrinG links VGSCs to the underly-
ing spectrin-based cytoskeleton and that this helps to
maintain the high local density of ion channels. Whereas
such a general model seems plausible for the NMJ, many
of the details remain uncertain. For example, the observa-
tions of this study suggest that the local density of VGSCs
is increased more within the folds than that of b-spectrin
and ankyrinG. Any interpretation of this depends on know-
ledge of the likely stoichiometric relationships between
these three proteins. At present it is not clear that every
VGSC must bind to one ankyrinG molecule or that oneThe Journal of Cell Biology, Volume 140, 1998 684
ankyrinG would have to bind to one b-spectrin molecule
for VGSCs to become localized to the membrane. Since
ankyrin is known to be capable of binding more than one
ion channel at a time (Michaely and Bennett, 1995), it is
possible that individual ankyrinG molecules would bind
multiple VGSCs. Furthermore, it is not clear what fraction
of b-spectrin molecules have ankyrinG bound to them or
that this is the same in J, PJ, or XJ regions of the muscle fi-
ber surface. Thus, although the observations of this study
show highly suggestive parallels in the density of VGSCs,
ankyrinG, and b-spectrin, the full significance of these re-
mains uncertain.
The precise colocalization of b-spectrin with both VGSCs
and ankyrinG at the NMJ suggests that interactions be-
tween these proteins play a role in the localization of VG-
SCs in muscle. Such a model has been proposed to account
for the local high density of VGSCs at axon hillocks and
initial segments, and at the nodes of Ranvier (Waxman
and Ritchie, 1985; Wollner and Catterall, 1986; Srinivasan
et al., 1988; Kordeli et al., 1990; Dugandzija-Novakovic et al.,
1995; Kaplan et al., 1997). Our findings in skeletal muscle
suggest that VGSC–ankyrinG–b-spectrin interactions may
be common to all excitable cells where VGSCs are found
at high density.
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